Skip to the page

Data / Drug companies / Sevelamer carbonate

Sevelamer carbonate: 35 companies and 51 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Sevelamer carbonate is listed in the FDA National Drug Code Directory by 35 companies, with 51 products in commercial distribution. 44 of the products (86.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; powder, for suspension; tablet, and the newest product started marketing on May 21, 2026.

The request: Get every company that lists sevelamer carbonate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
35
Products
51
Generic (ANDA) products
44 (86.3%)
Application numbers
18
Routes
Oral
Brand names
Renvela
openFDA record search
api.fda.gov

Companies that list sevelamer carbonate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Sanofi-Aventis U.S. LLC4powder, for suspension; tablet, film coatedAuthorized generics (NDA)July 14, 2023
Aurobindo Pharma Limited3powder, for suspension; tablet, film coatedGeneric drugs (ANDA)July 17, 2017
Genzyme Corporation3powder, for suspension; tablet, film coatedNew drug applications (NDA)August 12, 2009
Macleods Pharmaceuticals Limited3powder, for suspension; tablet, film coatedGeneric drugs (ANDA)April 26, 2024
Strides Pharma Science Limited3for suspension; tabletGeneric drugs (ANDA)July 2, 2024
Amneal Pharmaceuticals of New York LLC2powder, for suspensionGeneric drugs (ANDA)November 20, 2020
Bionpharma Inc.2powder, for suspensionGeneric drugs (ANDA)September 1, 2021
Cardinal Health 107, LLC2tablet, film coatedGeneric drugs (ANDA)September 29, 2017
Cipla USA Inc.2tablet, film coatedGeneric drugs (ANDA)October 26, 2017
Exelan Pharmaceuticals Inc.2tablet, film coatedGeneric drugs (ANDA)November 8, 2017
AiPing Pharmaceutical, Inc.1tabletGeneric drugs (ANDA)December 15, 2025
American Health Packaging1tablet, film coatedGeneric drugs (ANDA)August 22, 2017
Amneal Pharmaceuticals LLC1tablet, film coatedGeneric drugs (ANDA)November 28, 2017
Atlantic Biologicals Corp.1tablet, film coatedGeneric drugs (ANDA)June 27, 2018
AvKARE1tablet, film coatedGeneric drugs (ANDA)October 19, 2025
AvPAK1tablet, film coatedGeneric drugs (ANDA)January 14, 2019
Bryant Ranch Prepack1tablet, film coatedGeneric drugs (ANDA)April 19, 2023
Dr. Reddy's Laboratories Limited1tablet, film coatedGeneric drugs (ANDA)September 29, 2017
Golden State Medical Supply, Inc.1tablet, film coatedGeneric drugs (ANDA)September 29, 2017
Insignamedex LLC1tablet, film coatedGeneric drugs (ANDA)May 21, 2026
Major Pharmaceuticals1tablet, film coatedGeneric drugs (ANDA)September 29, 2017
Marp Pharma1tablet, film coatedGeneric drugs (ANDA)May 1, 2026
NCS HealthCare of Ky, LLC DBA Vangard Labs1tablet, film coatedGeneric drugs (ANDA)July 17, 2017
Navinta LLC1tablet, film coatedGeneric drugs (ANDA)November 1, 2025
NorthStar Rx LLC1tablet, film coatedGeneric drugs (ANDA)June 6, 2018
NorthStar RxLLC1powder, for suspensionGeneric drugs (ANDA)January 1, 2025
PD-Rx Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)December 15, 2025
Precision Dose, Inc.1tablet, film coatedGeneric drugs (ANDA)June 23, 2021
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)September 30, 2019
Shandong Xinhua Pharmaceutical Company Limited1tablet, film coatedGeneric drugs (ANDA)February 27, 2025
Upsher-Smith Laboratories, LLC1tablet, film coatedGeneric drugs (ANDA)September 30, 2019
Westminster Pharmaceuticals, LLC1tablet, film coatedGeneric drugs (ANDA)September 23, 2025
Zydus Lifesciences Limited1tablet, film coatedGeneric drugs (ANDA)September 17, 2020
Zydus Pharmaceuticals USA Inc.1tablet, film coatedGeneric drugs (ANDA)September 17, 2020
Zydus Pharmaceuticals USA Inc.1tablet, film coatedGeneric drugs (ANDA)April 1, 2026

Dosage forms

Dosage formProductsShare
Tablet, film coated3364.7%
Powder, for suspension1325.5%
Tablet35.9%
For suspension23.9%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)4486.3%
Authorized generics (NDA)47.8%
New drug applications (NDA)35.9%

Pharmacologic classes

ClassProducts
Phosphate Binder51

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.